ipilimumab,nivolumab
bms
[]
now for some escc updates from cm-648. original trends holding with with longer follow up. chemo-nivo and ipi/nivo both approved for escc. #gi23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.